These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 829632)

  • 1. [Immunosuppressive therapy of polymyositis].
    Gundlach HJ
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():26-30. PubMed ID: 829632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy in neurological diseases.
    Cendrowski W; Riekkinen PJ; Rinne UK
    Ann Clin Res; 1974 Dec; 6(6):323-9. PubMed ID: 4375431
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression.
    Dawkins RL; Mastaglia FL
    N Engl J Med; 1973 Mar; 288(9):434-8. PubMed ID: 4734262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic studies in polymyositis syndromes].
    Oehninger C; Rodríguez T; Passano R; Casanova E; Paciel J; Lasalvia E
    Acta Neurol Latinoam; 1979; 25(3-4):249-69. PubMed ID: 262355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive therapy in polymyositis (author's transl)].
    Vergara F; Ulloa P; Reginato A; Cartier L
    Rev Med Chil; 1978 Nov; 106(11):878-83. PubMed ID: 749110
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
    Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW
    Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in autoimmune pancytopenia: a case report and review of literature.
    Reale LD; Besa EC
    Ann Hematol; 2007 Dec; 86(12):913-6. PubMed ID: 17541587
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with immunosuppressive therapy in chronic aggressive hepatitis].
    Shimelpfenig V; Vagner K; Toier D; Shnaider G; Khekht A; Shimelpfenig R
    Vutr Boles; 1972; 11(3):120-3. PubMed ID: 4679965
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis.
    Desjardins V; Pelletier G; Leung TK; Waters D
    Can J Cardiol; 1992 Oct; 8(8):788-92. PubMed ID: 1422999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the treatment of autoimmune uveitis with prednisone and with cyclophosphamide and azathioprine].
    Flores M; Gudiño Pérez R; Ríos Prado R; Almedia Arvizu VM; Castrejón Vázquez MI; Ocampo AA
    Rev Alerg Mex; 2001; 48(3):75-9. PubMed ID: 11554127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of polymyositis with immunosuppressive drugs.
    Haas DC
    Neurology; 1973 Jan; 23(1):55-62. PubMed ID: 4734502
    [No Abstract]   [Full Text] [Related]  

  • 14. [Eosinophilic myositis of the extraocular muscles. A case report].
    Mitra S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Sep; 26(5):336-40. PubMed ID: 9931994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life saving cyclophosphamide treatment in a girl with giant cell hepatitis and autoimmune haemolytic anaemia: case report and up-to-date on therapeutical options.
    Vajro P; Migliaro F; Ruggeri C; Di Cosmo N; Crispino G; Caropreso M; Vecchione R
    Dig Liver Dis; 2006 Nov; 38(11):846-50. PubMed ID: 16266839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-74 treatment of autoimmune myositis.
    Petrányi G; Szegedi G
    Acta Med Acad Sci Hung; 1970; 27(4):351-6. PubMed ID: 5516086
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus nephritis: classification, clinical features, and treatment.
    Weissleder R; Galarza DA; Garza MA
    Rev Invest Clin; 1987; 39(3):263-76. PubMed ID: 3324251
    [No Abstract]   [Full Text] [Related]  

  • 19. [Theoretical basis of immunosuppression in autoimmune diseases].
    Haustein UF
    Dermatol Monatsschr; 1972 Aug; 158(8):547-71. PubMed ID: 4404036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aspects of immunosuppressive therapy of multiple sclerosis].
    Fischer W
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():23-6. PubMed ID: 829627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.